Monash IVF Group Limited (ASX:MVF)
0.7600
+0.0300 (4.11%)
Nov 17, 2026, 4:10 PM AEDT
Monash IVF Group Market Cap
Monash IVF Group has a market cap or net worth of 296.12 million as of November 16, 2026. It is the 20,340th most valuable company in the world and the 389th biggest in Australia. Its market cap has increased by 24.59% in one year.
Market Cap
296.12M
Enterprise Value
491.21M
Revenue
269.46M
Global Rank
Country Rank
#389 Australia
PE Ratio
40.00
ChartMarket Cap Chart
Since June 26, 2014, Monash IVF Group's market cap has decreased from 534.53M to 296.12M, a decrease of -44.60%. That is a compound annual growth rate of -4.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 296.12M | 3.40% |
| Dec 31, 2025 | 286.38M | -42.13% |
| Dec 31, 2024 | 494.84M | -2.31% |
| Dec 29, 2023 | 506.53M | 36.13% |
| Dec 30, 2022 | 372.10M | -9.48% |
| Dec 31, 2021 | 411.06M | 34.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 620.19M |
| Australian Clinical Labs | 619.90M |
| Healius | 417.54M |
| Identifai Genetics | 80.63M |
| Cryosite | 59.55M |
| Microba Life Sciences | 25.21M |
| Rhythm Biosciences | 23.36M |
| BCAL Diagnostics | 22.12M |